Ashley Henneghan

PhD, RN

Assistant Professor, Tenure-Track

The University of Texas at Austin

Ashley Henneghan is an Assistant Professor at the University of Texas at Austin School of Nursing.

Dr. Henneghan’s research is aimed at defining, treating, and ultimately preventing chronic symptoms and morbidities related to cancer and its treatment, which is a national health priority. Her NIH funded research has identified modifiable factors (including sleep quality, perceived stress, loneliness) in addition to biomarkers that increase survivors’ vulnerability to cognitive dysfunction following breast cancer treatment. Her ongoing work focuses on uncovering neurobiological mechanisms underlying cancer-related cognitive changes and developing evidence-based behavioral interventions to address these factors and improve survivors’ quality of life. Her research has had international reach and recognition through many peer-reviewed publications and presentations, and receipt of the 2018 New Investigator Award from the International Cancer and Cognition Task Force. Dr. Henneghan has served in leadership positions and led education initiatives on the late effects of breast cancer including presentations to support groups and nurses. She has also represented oncology nurses and patients by advocating on Capitol Hill in DC. Dr. Henneghan is now working with nursing scientists from the University of Colombia to assess the healthcare landscape of cancer survivorship care and establish research protocols to evaluate and improve survivor’ symptoms.

Dr. Henneghan received her BSN from the Pennsylvania State University, her MSN from the University of Texas at Austin, her PhD from the University of Texas at Austin, and her Postdoctoral Fellowship from the University of Texas MD Anderson Cancer Center.

American Academy of Nursing

1000 Vermont Ave NW • Suite 910
Washington, DC 20005-4903
(202) 777-1170 

conferences@aannet.org

  • Facebook
  • Twitter
  • LinkedIn

© 2020 American Academy of Nursing Community.  All rights reserved.

QUESTIONS? CONTACT US.